- Gilead to buy cancer drugmaker Immunomedics in $21 billion dealCNBC
- Gilead to acquire Immunomedics for $21 billionCNN
- Gilead Reaches Deal to Buy Immunomedics for $21 BillionThe Wall Street Journal
- Gilead Nears $20 Billion Deal for Immunomedics, WSJ SaysmsnNOW
- Gilead Ramps Up Cancer Focus With $21 Billion Immunomedics DealBloomberg
- View Full Coverage on Google News